RYTM News and Press, Rhythm Pharmaceuticals Inc. From 08/14/23

2023-08-14 07:00:00 ET Summary Biotech stocks faced challenges in the first half of the year, with the Nasdaq Biotechnology Index losing 3%, compared to strong advances in the broader market. The direction of the 10-year bond yield has become a key predictor of biotech industry pe...

-- Reimbursed early access program allows for patients with hypothalamic obesity in France to receive setmelanotide treatment -- -- Early access designation for hypothalamic obesity comes in addition to Bardet-Biedl syndrome -- BOSTON, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Rhythm Pharmace...

2023-08-06 12:00:54 ET Only a tiny fraction of adults in the U.S. are using prescription weight loss drugs, while many more are looking forward to taking them if the meds are proven to be safe and effective, a new survey by the healthcare policy organization Kaiser Family Foundation shows. ...

2023-08-04 15:08:00 ET Summary Rhythm Pharmaceuticals, Inc. is focused on developing treatments for orphan obesity syndromes caused by defects in the MC4R pathway. Their product Imcivree is currently approved for treating Bardet Biedel syndrome, POMC, PCSK1, and LEPR deficiencies....

2023-08-02 15:48:37 ET Summary Rhythm Pharmaceuticals' lead drug, Imcivree, has been approved for treating obesity due to specific genetic disorders. The company reported Q2 2023 revenue of $19.2 million, causing a 28% stock jump. Despite positive developments, I maintain a "S...

2023-08-01 14:47:56 ET More on Rhythm Pharmaceuticals Rhythm Pharmaceuticals, Inc. 2023 Q2 - Results - Earnings Call Presentation Rhythm Pharmaceuticals, Inc. ( RYTM ) Q2 2023 Earnings Call Transcript Rhythm Pharmaceuticals: Putting It On The Scale Again ...

2023-08-01 14:33:03 ET Start Time: 08:00 End Time: 08:51 Rhythm Pharmaceuticals, Inc. (RYTM) Q2 2023 Earnings Conference Call August 01, 2023, 08:00 AM ET Company Participants David Meeker - Chairman, President, and CEO Jennifer Chien - EVP, Head of North Ame...

2023-08-01 13:16:16 ET Gainers: Motorsport Games ( MSGM ) +86% . Yellow Corporation ( YELL ) +65% . ABVC BioPharma ( ABVC ) +51% . American Superconductor Corporation ( AMSC ) +50% . Evolve Transition Infrastructure LP ( OTC:SNMPD ) ...

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is one of today's top gainers. The company's shares are currently up 20.94% on the day to $21.57. Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the tre...

2023-08-01 10:04:48 ET Gainers: Adamis Pharmaceuticals ( ADMP ) +71% . ABVC BioPharma ( ABVC ) +49% . EQRx ( EQRX ) +18% . Rhythm Pharmaceuticals ( RYTM ) +17% . Esperion Therapeutics ( ESPR ) +6% . Losers: TG Therapeu...